Tag: Lutonix
FDA panel recommends against premarket approval of Lutonix 014 DCB for...
A Food and Drug Administration (FDA) advisory panel has recommended against premarket approval of BD’s Lutonix 014 drug-coated balloon (DCB) for use in below-the-knee (BTK) arteries....
IN.PACT Admiral DCB shows ‘significant advantage’ over uncoated devices in fempop...
The IN.PACT Admiral drug-coated balloon (DCB) demonstrated a significant advantage in overall survival, amputation-free survival and target-lesion revascularization after femoropopliteal artery treatment through four-year...